These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Efficacy and tolerance of dideoxynucleosides in HIV infection]. Molina JM Pathol Biol (Paris); 1992 Nov; 39(9):877-8. PubMed ID: 1311437 [No Abstract] [Full Text] [Related]
6. [Long-term observation on children. HIV-positive pregnant women: AZT therapy to be continued]. Gürtler L Fortschr Med; 1999 Mar; 117(8):6. PubMed ID: 10220949 [No Abstract] [Full Text] [Related]
7. Compliance with AZT treatment regimen of HIV-seropositive injection drug users: a neglected issue. Freeman RC; Rodriguez GM; French JF AIDS Educ Prev; 1996 Feb; 8(1):58-71. PubMed ID: 8703641 [TBL] [Abstract][Full Text] [Related]
9. AIDS. European trials of AZT to continue. Coles P Nature; 1989 Oct; 341(6244):678. PubMed ID: 2677750 [No Abstract] [Full Text] [Related]
10. The impact of ethanol and Marinol/marijuana usage on HIV+/AIDS patients undergoing azidothymidine, azidothymidine/dideoxycytidine, or dideoxyinosine therapy. Whitfield RM; Bechtel LM; Starich GH Alcohol Clin Exp Res; 1997 Feb; 21(1):122-7. PubMed ID: 9046384 [TBL] [Abstract][Full Text] [Related]
11. Zidovudine available to HIV-infected children. Am Fam Physician; 1990 Jan; 41(1):338, 341. PubMed ID: 2294673 [No Abstract] [Full Text] [Related]
12. Acute decrease in HIV-1 viral load after initiation of zidovudine therapy: implications for interrupting vertical transmission. Jackson JB Pediatr AIDS HIV Infect; 1995 Dec; 6(6):358-9. PubMed ID: 11361462 [TBL] [Abstract][Full Text] [Related]
13. [Controversies concerning the use of zidovudine in the treatment of asymptomatic HIV+ subjects with a low number of CD4+ lymphocytes]. Sarmati L; Vella S; Rocchi G Medicina (Firenze); 1990; 10(2):195-7. PubMed ID: 2273959 [No Abstract] [Full Text] [Related]
14. [Early treatment with zidovudine; a turning point in the campaign against AIDS?]. Lange JM; Goudsmit J Ned Tijdschr Geneeskd; 1989 Dec; 133(52):2599-601. PubMed ID: 2691897 [No Abstract] [Full Text] [Related]
15. HIV therapeutics: an emerging science. Bartlett JA JAMA; 1988 Nov; 260(20):3051-2. PubMed ID: 3054186 [No Abstract] [Full Text] [Related]
16. Persistent low plasma levels of HIV-1 in patients on AZT therapy and its implications. Camsonne R; Bustany P; Bigot MC; Pottier D; Moulin MA Therapie; 1994; 49(2):146-7. PubMed ID: 7817343 [No Abstract] [Full Text] [Related]
17. AIDS: when your patient refuses HIV testing. Kirton CA Am J Nurs; 1994 Nov; 94(11):48-53; quiz 53-4. PubMed ID: 7977507 [No Abstract] [Full Text] [Related]
18. Frequent isolation of HIV-1 from the blood of patients receiving zidovudine (AZT) therapy. Burke DS; Redfield RR; Bjornson DC; Fowler AK; Oster CN N Engl J Med; 1989 Dec; 321(24):1682. PubMed ID: 2586573 [No Abstract] [Full Text] [Related]
19. [Management of a subject with HIV positive serology]. Dubois D; Lacour JP Ann Dermatol Venereol; 1988; 115(6-7):747-51. PubMed ID: 2904787 [No Abstract] [Full Text] [Related]
20. All pregnant women advised to get HIV test, consider AZT therapy. AIDS Policy Law; 1995 Mar; 10(4):6-7. PubMed ID: 11362241 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]